Sharma_2022_Cureus_14_e30077

Reference

Title : A Rare Case Report of Sitagliptin-Induced Angioedema - Sharma_2022_Cureus_14_e30077
Author(s) : Sharma NR , Sharma B , Lamichhane S , Pokhrel M , Shrestha P
Ref : Cureus , 14 :e30077 , 2022
Abstract :

Sitagliptin, a dipeptidyl peptidase-4 inhibitor, is used for the treatment of type 2 diabetes mellitus. Sitagliptin-induced angioedema has increased with the simultaneous use of angiotensin receptor blockers and angiotensin-converting enzyme inhibitors. We present a rare case of a 50-year-old female diagnosed with sitagliptin-induced angioedema. On examination, she had both upper and lower lip swelling without any respiratory compromise. On further investigation, her C1 esterase inhibitor level was normal. After stopping sitagliptin, her symptoms resolved. Thus, cautious use of dipeptidyl peptidase-4 inhibitor is advised.

PubMedSearch : Sharma_2022_Cureus_14_e30077
PubMedID: 36381841

Related information

Inhibitor Sitagliptin

Citations formats

Sharma NR, Sharma B, Lamichhane S, Pokhrel M, Shrestha P (2022)
A Rare Case Report of Sitagliptin-Induced Angioedema
Cureus 14 :e30077

Sharma NR, Sharma B, Lamichhane S, Pokhrel M, Shrestha P (2022)
Cureus 14 :e30077